Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Neilsen

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 6, 2020
P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cellsBavani Gunasegaran, Paul M Neilsen, Scott D Smid
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
The oncogenic role of miR-155 in breast cancerSam Mattiske, Rachel J Suetani, Paul M Neilsen, et al.
Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.
FEBS Letters|February 2, 2010
CBFA2T3-ZNF651, like CBFA2T3-ZNF652, functions as a transcriptional corepressor complexRaman Kumar, Kelly M Cheney, Paul M Neilsen, et al.
ACS Chemical Biology|November 30, 2012
New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicityPaul M Neilsen, Ashok D Pehere, Kathleen I Pishas, et al.
Oncotarget|November 2, 2013
TAp63 regulates oncogenic miR-155 to mediate migration and tumour growthSam Mattiske, Kristen Ho, Jacqueline E Noll, et al.
Journal of Cellular Biochemistry|June 17, 2011
Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cellsRaman Kumar, Luke A Selth, Renee B Schulz, et al.
Oncology Letters|May 14, 2021
Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factorsReagan Entigu Linton, Maelinda Daker, Alan Soo-Beng Khoo, et al.
Virus Research|May 4, 2020
Natural product-derived phytochemicals as potential agents against coronaviruses: A reviewJanice S Mani, Joel B Johnson, Jason C Steel, et al.
Chemmedchem|October 17, 2013
A template-based approach to inhibitors of calpain 2, 20S proteasome, and HIV-1 proteaseSeth A Jones, Paul M Neilsen, Limei Siew, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 6, 2020
P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cellsBavani Gunasegaran, Paul M Neilsen, Scott D Smid
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
The oncogenic role of miR-155 in breast cancerSam Mattiske, Rachel J Suetani, Paul M Neilsen, et al.
Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.
FEBS Letters|February 2, 2010
CBFA2T3-ZNF651, like CBFA2T3-ZNF652, functions as a transcriptional corepressor complexRaman Kumar, Kelly M Cheney, Paul M Neilsen, et al.
ACS Chemical Biology|November 30, 2012
New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicityPaul M Neilsen, Ashok D Pehere, Kathleen I Pishas, et al.
Oncotarget|November 2, 2013
TAp63 regulates oncogenic miR-155 to mediate migration and tumour growthSam Mattiske, Kristen Ho, Jacqueline E Noll, et al.
Journal of Cellular Biochemistry|June 17, 2011
Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cellsRaman Kumar, Luke A Selth, Renee B Schulz, et al.
Oncology Letters|May 14, 2021
Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factorsReagan Entigu Linton, Maelinda Daker, Alan Soo-Beng Khoo, et al.
Virus Research|May 4, 2020
Natural product-derived phytochemicals as potential agents against coronaviruses: A reviewJanice S Mani, Joel B Johnson, Jason C Steel, et al.
Chemmedchem|October 17, 2013
A template-based approach to inhibitors of calpain 2, 20S proteasome, and HIV-1 proteaseSeth A Jones, Paul M Neilsen, Limei Siew, et al.
Pageof 3